Lisinopril versus amlodipine
Pro Research Analysisby 
Searched over 200M research papers
Comparative Analysis of Lisinopril and Amlodipine in Hypertension Management
Introduction to Hypertension Treatment
Hypertension, or high blood pressure, is a prevalent condition that significantly increases the risk of cardiovascular diseases. Two commonly prescribed medications for managing hypertension are lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, and amlodipine, a calcium channel blocker. This article synthesizes research comparing the efficacy, safety, and specific impacts of these two drugs.
Efficacy in Reducing Blood Pressure
Blood Pressure Control
Both lisinopril and amlodipine have been shown to effectively reduce systolic and diastolic blood pressure in hypertensive patients. Studies indicate that both drugs achieve significant reductions in blood pressure, with no substantial differences in overall efficacy when used as monotherapy 12. However, amlodipine has demonstrated a more consistent control of blood pressure over a 24-hour period compared to lisinopril, which shows its greatest effect during the daytime .
Combination Therapy
When used in combination, lisinopril and amlodipine provide an additive effect, resulting in a more significant reduction in blood pressure compared to either drug alone 49. This combination therapy is particularly effective in patients with stage 2 hypertension, achieving target blood pressure levels in a majority of patients .
Impact on Cardiovascular Health
Intima-Media Thickness (IMT)
The ELVERA trial compared the effects of lisinopril and amlodipine on intima-media thickness (IMT) in elderly hypertensive patients. Both drugs significantly reduced IMT, with no notable differences between the two treatments. However, amlodipine showed a more pronounced effect on the elastic common carotid artery .
Left Ventricular Mass and Diastolic Function
In terms of left ventricular mass and diastolic function, both lisinopril and amlodipine were found to be equally effective. The ELVERA trial reported similar reductions in left ventricular mass index (LVMI) and improvements in the early to atrial filling ratio (E/A ratio) for both drugs .
Safety and Tolerability
Adverse Events
Both lisinopril and amlodipine are generally well-tolerated. However, lisinopril has been associated with a higher incidence of certain adverse events, such as gastrointestinal bleeding and angioedema, compared to amlodipine . Additionally, lisinopril may lead to a higher rate of stroke in black patients and women .
Renal Function and Proteinuria
Lisinopril has shown a significant antiproteinuric effect, reducing proteinuria in patients with nondiabetic renal disease, whereas amlodipine did not significantly affect proteinuria . Lisinopril also induced a fall in glomerular filtration rate (GFR), which was not observed with amlodipine .
Conclusion
Both lisinopril and amlodipine are effective in managing hypertension, with each having unique benefits and potential drawbacks. Amlodipine provides more consistent blood pressure control over 24 hours and has fewer severe adverse effects, while lisinopril is more effective in reducing proteinuria and has a significant impact on renal function. The choice between these medications should be tailored to the individual patient's needs, considering factors such as race, gender, and specific health conditions.
Sources and full results
Most relevant research papers on this topic